367 related articles for article (PubMed ID: 26028034)
1. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.
Collins CT; Hess JL
Oncogene; 2016 Mar; 35(9):1090-8. PubMed ID: 26028034
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
Collins CT; Hess JL
Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
[TBL] [Abstract][Full Text] [Related]
3. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.
Collins C; Wang J; Miao H; Bronstein J; Nawer H; Xu T; Figueroa M; Muntean AG; Hess JL
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9899-904. PubMed ID: 24958854
[TBL] [Abstract][Full Text] [Related]
4. HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways.
Miyamoto R; Kanai A; Okuda H; Komata Y; Takahashi S; Matsui H; Inaba T; Yokoyama A
Elife; 2021 Jul; 10():. PubMed ID: 34310280
[TBL] [Abstract][Full Text] [Related]
5. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells.
Dorsam ST; Ferrell CM; Dorsam GP; Derynck MK; Vijapurkar U; Khodabakhsh D; Pau B; Bernstein H; Haqq CM; Largman C; Lawrence HJ
Blood; 2004 Mar; 103(5):1676-84. PubMed ID: 14604967
[TBL] [Abstract][Full Text] [Related]
6. HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.
Sun Y; Zhou B; Mao F; Xu J; Miao H; Zou Z; Phuc Khoa LT; Jang Y; Cai S; Witkin M; Koche R; Ge K; Dressler GR; Levine RL; Armstrong SA; Dou Y; Hess JL
Cancer Cell; 2018 Oct; 34(4):643-658.e5. PubMed ID: 30270123
[TBL] [Abstract][Full Text] [Related]
7. HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia.
Brumatti G; Salmanidis M; Kok CH; Bilardi RA; Sandow JJ; Silke N; Mason K; Visser J; Jabbour AM; Glaser SP; Okamoto T; Bouillet P; D'Andrea RJ; Ekert PG
Oncotarget; 2013 Nov; 4(11):1933-47. PubMed ID: 24177192
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
9. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.
Yoshino S; Yokoyama T; Sunami Y; Takahara T; Nakamura A; Yamazaki Y; Tsutsumi S; Aburatani H; Nakamura T
Blood; 2021 Jan; 137(1):75-88. PubMed ID: 32730594
[TBL] [Abstract][Full Text] [Related]
10. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
11. HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival.
Adamaki M; Lambrou GI; Athanasiadou A; Vlahopoulos S; Papavassiliou AG; Moschovi M
Leuk Res; 2015 Aug; 39(8):874-82. PubMed ID: 26059450
[TBL] [Abstract][Full Text] [Related]
12. Molecular regulators of HOXA9 in acute myeloid leukemia.
Aryal S; Zhang Y; Wren S; Li C; Lu R
FEBS J; 2023 Jan; 290(2):321-339. PubMed ID: 34743404
[TBL] [Abstract][Full Text] [Related]
13. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
14. Meis2 as a critical player in MN1-induced leukemia.
Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
[TBL] [Abstract][Full Text] [Related]
15. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
[TBL] [Abstract][Full Text] [Related]
16. Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen.
Zhang H; Zhang Y; Zhou X; Wright S; Hyle J; Zhao L; An J; Zhao X; Shao Y; Xu B; Lee HM; Chen T; Zhou Y; Chen X; Lu R; Li C
Elife; 2020 Oct; 9():. PubMed ID: 33001025
[TBL] [Abstract][Full Text] [Related]
17. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9.
Zhang M; Hyle J; Chen X; Xin Y; Jin Y; Zhang J; Yang X; Chen X; Wright S; Liu Z; Rosikiewicz W; Xu B; He L; Liu H; Ping N; Wu D; Wen F; Li C; Xu P
Genome Biol; 2024 Jan; 25(1):16. PubMed ID: 38216972
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation.
Steger J; Füller E; Garcia-Cuellar MP; Hetzner K; Slany RK
Leukemia; 2015 Apr; 29(4):901-8. PubMed ID: 25252870
[TBL] [Abstract][Full Text] [Related]
20. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc.
Garcia-Cuellar MP; Prinz A; Slany RK
Haematologica; 2022 Nov; 107(11):2601-2616. PubMed ID: 35546301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
